1082 related articles for article (PubMed ID: 33597531)
21. High-dimensional single-cell analysis reveals the immune characteristics of COVID-19.
Shi W; Liu X; Cao Q; Ma P; Le W; Xie L; Ye J; Wen W; Tang H; Su W; Zheng Y; Liu Y
Am J Physiol Lung Cell Mol Physiol; 2021 Jan; 320(1):L84-L98. PubMed ID: 33146564
[TBL] [Abstract][Full Text] [Related]
22. Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.
Bouayad A
Rev Med Virol; 2020 Nov; 30(6):1-9. PubMed ID: 32734714
[TBL] [Abstract][Full Text] [Related]
23. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
Matic S; Popovic S; Djurdjevic P; Todorovic D; Djordjevic N; Mijailovic Z; Sazdanovic P; Milovanovic D; Ruzic Zecevic D; Petrovic M; Sazdanovic M; Zornic N; Vukicevic V; Petrovic I; Matic S; Karic Vukicevic M; Baskic D
PLoS One; 2020; 15(12):e0241097. PubMed ID: 33382687
[TBL] [Abstract][Full Text] [Related]
24. Immune response against SARS-CoV-2 in pediatric patients including young infants.
Kawamura Y; Higashimoto Y; Miura H; Ihira M; Inaba M; Ito R; Kozawa K; Yoshikawa T
J Med Virol; 2021 Mar; 93(3):1776-1779. PubMed ID: 32897544
[TBL] [Abstract][Full Text] [Related]
25. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z
Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036
[TBL] [Abstract][Full Text] [Related]
26. Comprehensive Immune Profiling Reveals CD56
Dutt TS; LaVergne SM; Webb TL; Baxter BA; Stromberg S; McFann K; Berry K; Tipton M; Alnachoukati O; Zier L; Ebel G; Dunn J; Henao-Tamayo M; Ryan EP
J Immunol; 2022 Feb; 208(3):685-696. PubMed ID: 34987111
[TBL] [Abstract][Full Text] [Related]
27. Long-term infection of SARS-CoV-2 changed the body's immune status.
Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
[TBL] [Abstract][Full Text] [Related]
28. Identification of SARS-CoV-2-specific immune alterations in acutely ill patients.
Rébillard RM; Charabati M; Grasmuck C; Filali-Mouhim A; Tastet O; Brassard N; Daigneault A; Bourbonnière L; Anand SP; Balthazard R; Beaudoin-Bussières G; Gasser R; Benlarbi M; Moratalla AC; Solorio YC; Boutin M; Farzam-Kia N; Descôteaux-Dinelle J; Fournier AP; Gowing E; Laumaea A; Jamann H; Lahav B; Goyette G; Lemaître F; Mamane VH; Prévost J; Richard J; Thai K; Cailhier JF; Chomont N; Finzi A; Chassé M; Durand M; Arbour N; Kaufmann DE; Prat A; Larochelle C
J Clin Invest; 2021 Apr; 131(8):. PubMed ID: 33635833
[TBL] [Abstract][Full Text] [Related]
29. Neutralizing SARS-CoV-2.
Poeschla E
Elife; 2020 Dec; 9():. PubMed ID: 33320086
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection.
Cohen CA; Li APY; Hachim A; Hui DSC; Kwan MYW; Tsang OTY; Chiu SS; Chan WH; Yau YS; Kavian N; Ma FNL; Lau EHY; Cheng SMS; Poon LLM; Peiris M; Valkenburg SA
Nat Commun; 2021 Jul; 12(1):4678. PubMed ID: 34326343
[TBL] [Abstract][Full Text] [Related]
32. The known unknowns of T cell immunity to COVID-19.
Karlsson AC; Humbert M; Buggert M
Sci Immunol; 2020 Nov; 5(53):. PubMed ID: 33208380
[TBL] [Abstract][Full Text] [Related]
33. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
Brandstetter S; Roth S; Harner S; Buntrock-Döpke H; Toncheva AA; Borchers N; Gruber R; Ambrosch A; Kabesch M
Pediatr Allergy Immunol; 2020 Oct; 31(7):841-847. PubMed ID: 32413201
[TBL] [Abstract][Full Text] [Related]
34. How kids' immune systems can evade COVID.
Nogrady B
Nature; 2020 Dec; 588(7838):382. PubMed ID: 33303982
[No Abstract] [Full Text] [Related]
35. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
[TBL] [Abstract][Full Text] [Related]
36. Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France.
Gallais F; Velay A; Nazon C; Wendling MJ; Partisani M; Sibilia J; Candon S; Fafi-Kremer S
Emerg Infect Dis; 2021 Jan; 27(1):113-21. PubMed ID: 33261718
[TBL] [Abstract][Full Text] [Related]
37. Natural mucosal barriers and COVID-19 in children.
Pierce CA; Sy S; Galen B; Goldstein DY; Orner E; Keller MJ; Herold KC; Herold BC
JCI Insight; 2021 May; 6(9):. PubMed ID: 33822777
[TBL] [Abstract][Full Text] [Related]
38. Insight into the pediatric and adult dichotomy of COVID-19: Age-related differences in the immune response to SARS-CoV-2 infection.
Fialkowski A; Gernez Y; Arya P; Weinacht KG; Kinane TB; Yonker LM
Pediatr Pulmonol; 2020 Oct; 55(10):2556-2564. PubMed ID: 32710693
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2-Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study.
Trieu MC; Bansal A; Madsen A; Zhou F; Sævik M; Vahokoski J; Brokstad KA; Krammer F; Tøndel C; Mohn KGI; Blomberg B; Langeland N; Cox RJ;
J Infect Dis; 2021 Feb; 223(4):589-599. PubMed ID: 33247924
[TBL] [Abstract][Full Text] [Related]
40. Transcriptome of nasopharyngeal samples from COVID-19 patients and a comparative analysis with other SARS-CoV-2 infection models reveal disparate host responses against SARS-CoV-2.
Islam ABMMK; Khan MA; Ahmed R; Hossain MS; Kabir SMT; Islam MS; Siddiki AMAMZ
J Transl Med; 2021 Jan; 19(1):32. PubMed ID: 33413422
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
